Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2019
Price : $35 *
At a glance
- Drugs Ustekinumab (Primary)
- Indications Atopic dermatitis; Crohn's disease; Psoriatic arthritis
- Focus Adverse reactions
- 07 Oct 2019 Planned End Date changed from 1 Jul 2020 to 1 Jul 2022.
- 07 Oct 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2020.
- 07 Oct 2019 Status changed from recruiting to active, no longer recruiting.